financetom
Business
financetom
/
Business
/
U.S.-China Trade Talks to Start Soon, Notes ABN Amro
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
U.S.-China Trade Talks to Start Soon, Notes ABN Amro
May 26, 2025 2:41 AM

06:36 AM EDT, 05/07/2025 (MT Newswires) -- Another important development this week relates to the progress with United States-China talks, following the sharp escalation in April, with bilateral tariffs skyrocketing, said ABN Amro.

U.S. tariffs on China's good are at 145% while vice versa they are 125%.

While the U.S., pressured by financial markets and corporate lobbying, had already exempted consumer electronics and car parts from these high country-specific tariffs, recently U.S. officials were increasing their calls on China to get to the negotiation table, wrote the bank in a notet.

China initially played 'hard to get', but a more conciliatory tone was seen more recently and late Tuesday, it was announced that talks on de-escalation between the two giants will be held this weekend in Switzerland, pointed out ABN Amro.

The U.S. delegation will be led by Treasury Secretary Scott Bessent and Trade Representative Jamieson Greer, while Vice Premier He Lifeng will lead the Chinese delegation.

Although China has several reasons to play it "tough," the bank still thinks that both countries could benefit from de-escalation, given the big interests at stake and the fact that the trade war is damaging for both the U.S. and Chinese economies.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AstraZeneca switches to direct US listing, keeps UK listing
AstraZeneca switches to direct US listing, keeps UK listing
Sep 28, 2025
(Reuters) -AstraZeneca ( AZN ) said on Monday it would now directly list its shares on the New York Stock Exchange, instead of the current depository shares, and that it would remain listed and headquartered in London in a vote of confidence for the UK. The move comes after reports that the Anglo-Swedish drugmaker, which is London's most valuable company,...
AstraZeneca to directly list shares in New York, retain UK listing
AstraZeneca to directly list shares in New York, retain UK listing
Sep 28, 2025
Sept 29 (Reuters) - AstraZeneca ( AZN ) said on Monday that it will now directly list its shares on the New York Stock Exchange, instead of the current depository shares, adding that it will continue to be listed and headquartered in the UK. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Mrigank Dhaniwala) ...
Genmab to buy Dutch cancer drugmaker Merus for $8 billion
Genmab to buy Dutch cancer drugmaker Merus for $8 billion
Sep 28, 2025
* Genmab ( GMAB ) to pay $97 per Merus share, a 41% premium * Transaction recommended by both boards * Biotech Merus develops head-and-neck cancer drug * Genmab ( GMAB ) eyes growth well into the next decade (Adds CEO quotes, share price, timing of potential drug launch in paragraphs 2, 3-5) OSLO, Sept 29 (Reuters) - Denmark's Genmab...
TotalEnergies to sell 50% of North American solar portfolio in $950 million deal
TotalEnergies to sell 50% of North American solar portfolio in $950 million deal
Sep 28, 2025
(Reuters) -TotalEnergies will sell 50% of a solar portfolio in North America to investment firm KKR, the energy major said on Monday, adding it will receive $950 million from the sale and bank refinancing. The sale includes six utility-scale solar assets and 41 distributed generation assets, mostly in the United States, TotalEnergies said in a statement. The company said that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved